Recursion reports second-quarter revenue of $19.22 million, beating analyst estimates of $16.23 million. Recursion reports a second-quarter loss of 41 cents per share, missing estimates for a loss of 34 cents per share. The market's back, and these 3 income stocks are thriving. See them here→

RXRX

<p>Recursion 报告第二季度收入为 1922 万美元，超出分析师预期的 1623 万美元。Recursion 报告第二季度每股亏损 41 美分，未能达到预期的每股亏损 34 美分。市场回暖，这三只收益股票表现良好。点击这里查看→</p>

Recursion Pharmaceuticals 报告第二季度亏损大于预期，但收入超过预期